Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1964 6
1966 2
1969 1
1970 1
1976 1
1977 2
1981 1
1983 1
1985 1
1986 1
1988 1
1990 2
2007 1
2008 6
2009 4
2011 3
2012 1
2014 1
2017 2
2018 1
2020 2
2021 4
2024 6
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.
Parker CC, Kynaston H, Cook AD, Clarke NW, Catton CN, Cross WR, Petersen PM, Persad RA, Pugh CA, Saad F, Logue J, Payne H, Bower LC, Brawley C, Rauchenberger M, Barkati M, Bottomley DM, Brasso K, Chung HT, Chung PWM, Conroy R, Falconer A, Ford V, Goh CL, Heath CM, James ND, Kim-Sing C, Kodavatiganti R, Malone SC, Morris SL, Nabid A, Ong AD, Raman R, Rodda S, Wells P, Worlding J, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 Jun 1;403(10442):2416-2425. doi: 10.1016/S0140-6736(24)00549-X. Epub 2024 May 16. Lancet. 2024. PMID: 38763153 Free PMC article. Clinical Trial.
When Benchmarks Fail Us: A Case Study in Cytoreductive Surgery.
Bansal VV, Witmer HDD, Childers CP, Su DG, Turaga KK; RVU Writing Group; PSM Consortium Group. Bansal VV, et al. Ann Surg Oncol. 2025 Jan;32(1):19-23. doi: 10.1245/s10434-024-16191-y. Epub 2024 Oct 26. Ann Surg Oncol. 2025. PMID: 39460818
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
Parker CC, Clarke NW, Cook AD, Kynaston H, Catton CN, Cross WR, Petersen PM, Persad RA, Saad F, Bower LC, Logue J, Payne H, Forcat S, Goldstein C, Murphy C, Anderson J, Barkati M, Bottomley DM, Branagan J, Choudhury A, Chung PWM, Cogley L, Goh CL, Hoskin P, Khoo V, Malone SC, Masters L, Morris SL, Nabid A, Ong AD, Raman R, Tarver KL, Tree AC, Worlding J, Wylie JP, Zarkar AM, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 Jun 1;403(10442):2405-2415. doi: 10.1016/S0140-6736(24)00548-8. Epub 2024 May 16. Lancet. 2024. PMID: 38763154 Free PMC article. Clinical Trial.
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.
Leone G, Orlando F, Dutey-Magni P, Vainauskas O, Grist E, Ciani Y, Lall S, Thakali S, Wingate A, Wetterskog D, Sachdeva A, Sydes MR, McPhail N, Sreenivasan T, O'Sullivan JM, Clarke NW, Parmar MKB, Brown LC, James ND, Demichelis F, Attard G; STAMPEDE collaborators. Leone G, et al. JAMA Oncol. 2025 Feb 27;11(4):426-9. doi: 10.1001/jamaoncol.2024.7051. Online ahead of print. JAMA Oncol. 2025. PMID: 40014335
Intraperitoneal Chemotherapy: A Call to Study Reproductive Safety for Healthcare Workers.
Gupta P, Godfrey EL, Schultz KS, Yu LJ, Bansal VV, Gomez-Mayorga J, Papageorge M, Proussaloglou EM, Su DG, Merl MY, Ward E, Sood D, Magge DR, Senthil M, Kopecky KE, Turaga KK, Sarpel U; Peritoneal Surface Malignancies (PSM) Consortium Group. Gupta P, et al. Ann Surg Oncol. 2025 Aug 28. doi: 10.1245/s10434-025-18051-9. Online ahead of print. Ann Surg Oncol. 2025. PMID: 40877725 No abstract available.
Consensus Guideline for the Management of Gastric Cancer with Synchronous Peritoneal Metastases.
Butensky SD, Bansal VV, Su DG, Waheed MT, Nikiforchin A, Gomez-Mayorga JL, Olecki E, Radomski SN, Sun B, Turaga KK, Gunderson CG, Lacy J, Badgwell BD, In H, Kennedy T, Yoon HH, Greer JB, Sundar R, Woo Y; Peritoneal Surface Malignancies (PSM) Consortium Group. Butensky SD, et al. Ann Surg Oncol. 2025 Jun 25. doi: 10.1245/s10434-025-17361-2. Online ahead of print. Ann Surg Oncol. 2025. PMID: 40560499 Review.
Consensus guideline for the management of gastric cancer with synchronous peritoneal metastases.
Butensky SD, Bansal VV, Su DG, Waheed MT, Nikiforchin A, Gomez-Mayorga JL, Olecki E, Radomski SN, Sun B, Turaga KK, Gunderson CG, Lacy J, Badgwell BD, In H, Kennedy T, Yoon HH, Greer JB, Sundar R, Woo Y; Peritoneal Surface Malignancies Consortium Group. Butensky SD, et al. Cancer. 2025 Jul 1;131(13):e35870. doi: 10.1002/cncr.35870. Cancer. 2025. PMID: 40558029
Consensus guideline for the management of colorectal cancer with peritoneal metastases.
Schultz KS, Bansal VV, Wach MM, Bhutiani N, Godley FA 4th, Wang JJ, Waheed MT, Buchheit JT, Papai E, Campbell S, Schleimer LE, Su DG, Turaga KK, Gunderson CG, White MG, Uppal A, Raghav KPS, Labow DM, Sarpel U, Shergill AP, Shen JP, Eng C, Foote MB, Baumgartner JM; Peritoneal Surface Malignancies Consortium Group. Schultz KS, et al. Cancer. 2025 Jul 1;131(13):e35869. doi: 10.1002/cncr.35869. Cancer. 2025. PMID: 40558054
Consensus Guideline for the Management of Colorectal Cancer with Peritoneal Metastases.
Schultz KS, Bansal VV, Wach MM, Bhutiani N, Godley FA 4th, Wang JJ, Waheed MT, Buchheit JT, Papai E, Campbell S, Schleimer LE, Su DG, Turaga KK, Gunderson CG, White MG, Uppal A, Raghav KPS, Labow DM, Sarpel U, Shergill AP, Shen JP, Eng C, Foote MB, Baumgartner JM; Peritoneal Surface Malignancies (PSM) Consortium Group. Schultz KS, et al. Ann Surg Oncol. 2025 Jun 25. doi: 10.1245/s10434-025-17363-0. Online ahead of print. Ann Surg Oncol. 2025. PMID: 40560497 Review.
58 results